The Relationship between Timing of Initiation on a Glucagon-Like Peptide-1 Receptor Agonist and HbA1c among Patients with Type 2 Diabetes

被引：0
|
作者：
Malik, Raleigh E.
Mody, Reema
Lage, Maureen J.
Boye, Kristina
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-938-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
938-P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Decreased Hypothalamic Glucagon-Like Peptide-1 Receptor Expression in Type 2 Diabetes Patients
    ten Kulve, Jennifer S.
    van Bloemendaal, Liselotte
    Balesar, Rawien
    IJzerman, Richard G.
    Swaab, Dick F.
    Diamant, Michaela
    la Fleur, Susanne E.
    Alkemade, Anneke
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (05): : 2122 - 2129
  • [22] COPD Exacerbations in Patients With Type 2 Diabetes on Glucagon-like Peptide-1 Receptor Agonists
    Foer, D.
    Strasser, Z. H.
    Cui, J.
    Cahill, K. N.
    Murphy, S. N.
    Karlson, E. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [23] Kidney Outcomes With Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes
    Mosenzon, Ofri
    Schechter, Meir
    Leibowitz, Gil
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2021, 28 (04) : 347 - 360
  • [24] Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes
    Tran, Kelvin Lingjet
    Park, Young In
    Pandya, Shalin
    Muliyil, Navin John
    Jensen, Brandon David
    Huynh, Kovin
    Nguyen, Quang T.
    AMERICAN HEALTH AND DRUG BENEFITS, 2017, 10 (04): : 178 - 187
  • [25] Albiglutide: A once-weekly glucagon-like peptide-1 receptor agonist for type 2 diabetes mellitus
    Davis, Portia N.
    Ndefo, Uche Anadu
    Oliver, Ashley
    Payton, Enryka
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (13) : 1097 - 1103
  • [26] Trends in obesity and glucagon-like peptide-1 receptor agonist prescriptions in type 1 diabetes in the United States
    Xu, Yunwen
    Tcheugui, Justin B. Echouffo
    Coresh, Josef
    Grams, Morgan E.
    Selvin, Elizabeth
    Fang, Michael
    Shin, Jung-Im
    DIABETES OBESITY & METABOLISM, 2025,
  • [27] PRESENT AND FUTURE OF THE RELATIONSHIP BETWEEN GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS AND INSULIN FOR THE TREATMENT OF TYPE 2 DIABETES
    Pozzilli, Paolo
    Napoli, Nicola
    Naciu, Anda Mihaela
    Soare, Andreea
    INTERDIAB 2017: DIABETES MELLITUS IN INTERNAL MEDICINE, 2017, : 78 - 85
  • [28] Glucagon-Like Peptide-1 and Diabetes
    Monami, Matteo
    EXPERIMENTAL DIABETES RESEARCH, 2011,
  • [29] Glucagon-Like Peptide-1 Receptor Agonist Use and Asthma Exacerbations Among Type 2 Diabetics with Asthma
    Foer, D.
    Beeler, P. E.
    Cui, J.
    Karlson, E.
    Bates, D. W.
    Cahill, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [30] The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes in Asia
    Ju-Ming Lu
    Advances in Therapy, 2019, 36 : 798 - 805
12345